CVS HEALTH Corp (CVS) operating KPIs
CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/3016% above fair value
$90.25−0.08 (-0.09%)
Close on Oct 30, 2026Market cap $115.43BP/E 23.9Yield 2.95%
Cvs Health centene Corporation (CNC) — Medical Claims Liability ($M)
Quarterly figures from Cvs Health's filings and investor materials
Latest, Q3 2026
21,495
Period ended Sep 30, 2026
Change on a year earlier
0.0%
21,493 in Q3 2025
History
43 quarters
Since Q1 2016
Sources
2
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Centene Corporation (CNC) — Medical Claims Liability ($M) | Year on year | Source |
|---|---|---|---|---|
| Q3 2026 | Sep 30, 2026 | 21,495 | 0.0% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q2 2026 | Jun 30, 2026 | 20,262 | +0.7% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q1 2026 | Mar 31, 2026 | 20,627 | +3.6% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q4 2025 | Dec 31, 2025 | 20,544 | +12.2% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q3 2025 | Sep 30, 2025 | 21,493 | +19.4% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q2 2025 | Jun 30, 2025 | 20,117 | +10.7% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q1 2025 | Mar 31, 2025 | 19,911 | +10.0% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q4 2024 | Dec 31, 2024 | 18,308 | +1.7% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q3 2024 | Sep 30, 2024 | 17,995 | +5.0% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q2 2024 | Jun 30, 2024 | 18,173 | +7.6% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q1 2024 | Mar 31, 2024 | 18,109 | +3.5% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q4 2023 | Dec 31, 2023 | 18,000 | +7.5% | Centene Corp. SEC 10-K (XBRL) ↗ |
| Q3 2023 | Sep 30, 2023 | 17,141 | +4.1% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q2 2023 | Jun 30, 2023 | 16,884 | +1.8% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q1 2023 | Mar 31, 2023 | 17,504 | +7.7% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q4 2022 | Dec 31, 2022 | 16,745 | +17.6% | Centene Corp. SEC 10-K (XBRL) ↗ |
| Q3 2022 | Sep 30, 2022 | 16,465 | +16.8% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q2 2022 | Jun 30, 2022 | 16,581 | +29.9% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q1 2022 | Mar 31, 2022 | 16,259 | +26.6% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q4 2021 | Dec 31, 2021 | 14,243 | +14.5% | Centene Corp. SEC 10-K (XBRL) ↗ |
| Q3 2021 | Sep 30, 2021 | 14,099 | +9.3% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q2 2021 | Jun 30, 2021 | 12,763 | +11.8% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q1 2021 | Mar 31, 2021 | 12,842 | +12.5% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q4 2020 | Dec 31, 2020 | 12,438 | +66.4% | Centene Corp. SEC 10-K (XBRL) ↗ |
| Q3 2020 | Sep 30, 2020 | 12,899 | +61.7% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q2 2020 | Jun 30, 2020 | 11,418 | +53.3% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q1 2020 | Mar 31, 2020 | 11,413 | +54.6% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q4 2019 | Dec 31, 2019 | 7,473 | +9.4% | Centene Corp. SEC 10-K (XBRL) ↗ |
| Q3 2019 | Sep 30, 2019 | 7,975 | +14.2% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q2 2019 | Jun 30, 2019 | 7,447 | +48.9% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q1 2019 | Mar 31, 2019 | 7,381 | +54.7% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q4 2018 | Dec 31, 2018 | 6,831 | +59.4% | Centene Corp. SEC 10-K (XBRL) ↗ |
| Q3 2018 | Sep 30, 2018 | 6,983 | +61.2% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q2 2018 | Jun 30, 2018 | 5,003 | +20.0% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q1 2018 | Mar 31, 2018 | 4,771 | +11.2% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q4 2017 | Dec 31, 2017 | 4,286 | +9.1% | Centene Corp. SEC 10-K (XBRL) ↗ |
| Q3 2017 | Sep 30, 2017 | 4,333 | +15.0% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q2 2017 | Jun 30, 2017 | 4,170 | +5.6% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q1 2017 | Mar 31, 2017 | 4,290 | +11.1% | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q4 2016 | Dec 31, 2016 | 3,929 | – | Centene Corp. SEC 10-K (XBRL) ↗ |
| Q3 2016 | Sep 30, 2016 | 3,767 | – | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q2 2016 | Jun 30, 2016 | 3,950 | – | Centene Corp. SEC 10-Q (XBRL) ↗ |
| Q1 2016 | Mar 31, 2016 | 3,863 | – | Centene Corp. SEC 10-Q (XBRL) ↗ |
Cite this data
StockData. (2026). Cvs Health Centene Corporation (CNC) — Medical Claims Liability ($M), quarterly Q1 2016–Q3 2026 [Data set]. Compiled from Cvs Health SEC filings and investor materials. https://stockdatahq.com/stocks/cvs/kpis/peer_cnc_med_payable
See every metric in the Cvs Health KPI table. Data updated Oct 28, 2026.